For psoriasis, subcutaneous injection offers several advantages
Here are some of its key benefits: 1
Therefore, seen from the viewpoint of the inflammatory bowel disease-multiple sclerosis connections throughout BPC 157, the final proof should be the corresponding effectiveness in both models, multiple sclerosis as well as ulcerative colitis
Key Peptides That Support Prolotherapy It is recommended to use a combination of injectable peptides to enhance the benefits of prolotherapy, including: GLOW (BPC-157 + TB-500 + GHK-Cu) GLOW is a proprietary blend of three synergistic peptides designed to promote comprehensive tissue regeneration: BPC-157 (5mg) : Enhances tendon and ligament healing, reduces inflammation, improves angiogenesis TB-500 (10mg) : Supports cell migration, modulates inflammation, prevents scar tissue GHK-Cu (27mg) : Stimulates collagen and elastin, improves skin and soft tissue repair GLOW is ideal in the early healing phase post-prolotherapy to amplify fibroblast activity and new capillary formation , both crucial for regenerative success

Peptide clears from blood BUT cellular processes continue Duration of cellular effects: Why this matters: Don't need continuous high levels in blood Single injection triggers multi-day effects 2-3x weekly dosing sufficient (not daily required) Cellular "memory" of GHK-Cu exposure Cumulative effects with repeated dosing: Each dose builds on previous Collagen accumulation over weeks Tissue remodeling compounds Results improve with consistent use Comparing GHK-Cu to other peptides Half-life comparison table: GHK-Cu positioning: Short half-life like Ipamorelin But longer cellular effects than half-life suggests Middle-ground dosing frequency (not daily, not weekly) Cumulative benefits with consistency See our BPC-157 guide , TB-500 guide , peptide dosing guide , and peptide dosage chart
2026 Apr;652(8110):740-751